Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,805 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07592767RecruitingPhase 2
Resveratrol supplement for Parkinson's disease
This study tests whether a supplement called resveratrol (found naturally in grapes and berries) can help slow or improve Parkinson's disease symptoms. You'll take resveratrol pills or a placebo while researchers monitor your memory, movement, and overall health.
Washington D.C., District of ColumbiaAges 55–85 - NCT07579078Enrolling by invitation
Vitamin D and Brain Activity in Women With Depression
This study tests whether vitamin D supplements can improve brain wave patterns in women diagnosed with depression who have low vitamin D levels. Researchers will measure brain activity using EEG (a non-invasive test that records electrical signals from the brain) before and after vitamin D treatment.
DhakaAges 20–40 - NCT07561528Recruiting
Brain Stimulation for Hard-to-Treat Obsessive-Compulsive Disorder
This study tests whether a type of brain stimulation called transcranial magnetic stimulation (TMS)—which uses magnetic pulses to activate brain cells—can help people with OCD whose symptoms haven't improved with medication. Researchers will also look at brain activity patterns to understand who benefits most.
Istanbul, BakirkoyAges 18–65 - NCT07567664Enrolling by invitation
Brain Changes in Neurodegenerative Diseases: A Tracking Study
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
Milan, LombardyAges 20–85 - NCT07559500RecruitingPhase 1
Study of tirzepatide for alcohol use disorder
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
Bethesda, MarylandAges 21–65 - NCT07551258Recruiting
Immune System Changes and Lung Infection in Critically Ill Older Adults
This study looks at how the immune system changes in older patients on breathing machines in the ICU, and whether these changes affect the risk of developing pneumonia. Understanding this may help doctors better protect critically ill patients from infection.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT07545317Recruiting
IL-23 Inhibitors for Active Crohn's Disease
This study follows patients with moderate-to-severe Crohn's disease who are starting a newer type of biologic medication called IL-23 inhibitors (guselkumab or risankizumab). Researchers want to understand how well these drugs work in real-world clinical practice and compare their effectiveness to other treatments.
Guangzhou, GuangdongAges 18–75 - NCT07540338RecruitingPhase 1/Phase 2
New Lithium Capsule Study for Bipolar I
This study compares a new lithium capsule (AL001) to a standard lithium capsule in people with Bipolar I Disorder. It aims to see how well your body absorbs each capsule and whether AL001 is safer or more tolerable.
Boston, MassachusettsAges 18–65 - NCT07531342Recruiting
Brain Stimulation and Diet for Severe Crohn's Disease
This study tests whether repetitive transcranial magnetic stimulation (a non-invasive brain treatment) combined with an anti-inflammatory diet can help people with severe, treatment-resistant Crohn's disease feel better. The brain stimulation uses magnetic pulses on the scalp to reduce inflammation and improve symptoms.
Giza, Giza GovernorateAges 40–60 - NCT07513181RecruitingPhase 2
Testing ATH-063 for Hard-to-Treat Ulcerative Colitis
This study tests a new drug called ATH-063 to see if it can help people with moderate-to-severe ulcerative colitis (a condition causing inflammation and bleeding in the colon) who haven't responded well to previous biologic treatments. The goal is to find out if this new drug is safe and effective.
Miami, FloridaAges 18–75 - NCT06104176Recruiting
Virtual reality therapy for alcohol use disorder
This study tests if virtual reality therapy can help people with alcohol use disorder stay abstinent. You must be sober for at least 15 days to participate.
Créteil, Île-de-France RegionAges 18–80 - NCT07490600Recruiting
Testing brain stimulation and rewards for quitting cocaine
This trial combines deep transcranial magnetic stimulation (TMS) with a reward program (contingency management) to help people stop using cocaine. It may help if you are struggling with moderate to severe cocaine use and want a non-drug treatment.
Houston, TexasAges 18–65 - NCT07498335RecruitingPhase 3
Atrasentan for children with IgA nephropathy
This trial tests an experimental medicine called atrasentan for children aged 2 to under 18 with IgA nephropathy, a kidney disease. The study aims to see if the drug can help protect kidney function and reduce protein in the urine, with fewer side effects than current treatments.
Neptune City, New JerseyAges 2–18 - NCT07494409RecruitingPhase 3
A new oral medicine for anemia in dialysis patients
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
ShanghaiAges 18–75 - NCT07487727RecruitingPhase 3
Study of an experimental anemia drug for chronic kidney disease patients not on dialysis
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT07477821Recruiting
Muscle and brain health study in aging and neurological disorders
This study looks at the link between muscle health and brain function in people with different neurological conditions or healthy aging. It may help researchers understand how muscle changes relate to memory, movement, and thinking problems.
CataniaAges 60 years+ - NCT07463287Recruiting
Fatty liver and colorectal polyp risk study
This study looks at whether certain gene activity in people with fatty liver disease can predict the risk of developing colorectal polyps. It may help doctors find high-risk patients earlier.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05715710Recruiting
MRI and brain vein pattern study for memory and thinking problems
This study looks at whether certain deep brain veins seen on MRI are linked to thinking and memory problems in people with small-vessel brain disease. It compares brain scan findings with cognitive (thinking) testing to better understand what may drive cognitive dysfunction.
Zigong, SichuanAges 50–85 - NCT07460947RecruitingPhase 1/Phase 2
One-day TMS and medicine for suicidal thoughts in BPD
This trial tests if a single day of accelerated transcranial magnetic stimulation (TMS) combined with the medication D-cycloserine can reduce suicidal thoughts in people with borderline personality disorder (BPD). It aims to find a fast-acting treatment option for those who are struggling.
Belmont, MassachusettsAges 18 years+ - NCT07452250RecruitingPhase 2
Ferumoxytol-enhanced MRI for vein problems
This trial uses a special iron-based contrast agent called ferumoxytol during an MRI scan to get clearer pictures of your veins. It's for people who may have vein blockages or other vein issues that need better imaging.
Nanjing, JiangsuAges 18 years+ - NCT07452744Enrolling by invitation
Picroliv for non-alcoholic fatty liver disease
This study tests a plant-based medicine called Picroliv for people with non-alcoholic fatty liver disease (NAFLD). It aims to see if it is safe and can reduce fat in the liver.
Chandigarh, ChandigarhAges 18–60 - NCT07441915Recruiting
Sleep Sounds and Brain Training for Parkinson's with Mild Memory Problems
This trial tests whether playing soft sounds during sleep can boost the effects of a computer-based brain training program in people with Parkinson's disease who have mild memory or thinking issues. If you qualify, you'll use a headband that plays tones while you sleep and do brain exercises for several weeks.
Zurich, Canton of ZurichAges 18 years+ - NCT07427940Recruiting
Genetics and autism: a study of the omic profile
This study looks at the genetic and molecular profiles of children with autism spectrum disorder (ASD) to better understand the condition and find new treatments. It compares children with ASD who have no known genetic cause to those with a specific genetic syndrome.
MilanAges 3–15 - NCT07420283RecruitingPhase 2
Study of Brenipatide for opioid use disorder
This trial tests a new medicine called Brenipatide for people with opioid use disorder who are already taking buprenorphine but still occasionally use non-prescribed opioids. It aims to see if the study drug can help reduce opioid use.
Phoenix, ArizonaAges 18–75
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,805 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.